Fundraising Fox
FIRE1
Dublin, IE · Founded 2014 · 110 employees on LinkedIn · 15 known investors
Find your way into FIRE1
Sign up to find every way you can get introduced to FIRE1
- Your email: who you already know at FIRE1, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the FIRE1 team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
FIRE1 develops NORM, an implantable sensor placed in the inferior vena cava to directly measure fluid volume in heart failure patients, paired with a self-management platform to help patients engage with their own care. The company runs clinical trials across Europe and the US for people living with heart failure.
Investors · 15
How we know: Andera Partners's portfolio page · funding news · fiercebiotech.com · Not right? Tell us
How we know: Gimv's portfolio page · itdigest.com · Not right? Tell us
How we know: Ireland Strategic Investment Fund's portfolio page · fiercebiotech.com · Not right? Tell us
How we know: Lightstone Ventures's portfolio page · funding news · fiercebiotech.com · the VCSheet dataset · Not right? Tell us
How we know: Longitude Capital's portfolio page · itdigest.com · the VCSheet dataset · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: Seventure Partners's portfolio page · itdigest.com · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements- Undisclosed amountextension roundMar 2023
Andera Partners (lead), Novo Holdings (lead), Ireland Strategic Investment Fund, Lightstone Ventures, Medtronic
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does FIRE1 do?
- FIRE1 develops NORM, an implantable sensor placed in the inferior vena cava to directly measure fluid volume in heart failure patients, paired with a self-management platform to help patients engage with their own care. The company runs clinical trials across Europe and the US for people living with heart failure.
- Who are FIRE1's investors?
- FIRE1's investors include Andera Partners, Gimv, Ireland Strategic Investment Fund, Lightstone Ventures, Longitude Capital, New Enterprise Associates (NEA), Seventure Partners, Gilde Healthcare and 4 more.
- Where is FIRE1 headquartered?
- FIRE1 is headquartered in Dublin, IE.